These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34247342)

  • 1. The negative impact of obesity on the occurrence and prognosis of the 2019 novel coronavirus (COVID-19) disease: a systematic review and meta-analysis.
    Raeisi T; Mozaffari H; Sepehri N; Darand M; Razi B; Garousi N; Alizadeh M; Alizadeh S
    Eat Weight Disord; 2022 Apr; 27(3):893-911. PubMed ID: 34247342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity in patients with COVID-19: a systematic review and meta-analysis.
    Huang Y; Lu Y; Huang YM; Wang M; Ling W; Sui Y; Zhao HL
    Metabolism; 2020 Dec; 113():154378. PubMed ID: 33002478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity as an independent risk factor for COVID-19 severity and mortality.
    Tadayon Najafabadi B; Rayner DG; Shokraee K; Shokraie K; Panahi P; Rastgou P; Seirafianpour F; Momeni Landi F; Alinia P; Parnianfard N; Hemmati N; Banivaheb B; Radmanesh R; Alvand S; Shahbazi P; Dehghanbanadaki H; Shaker E; Same K; Mohammadi E; Malik A; Srivastava A; Nejat P; Tamara A; Chi Y; Yuan Y; Hajizadeh N; Chan C; Zhen J; Tahapary D; Anderson L; Apatu E; Schoonees A; Naude CE; Thabane L; Foroutan F
    Cochrane Database Syst Rev; 2023 May; 5(5):CD015201. PubMed ID: 37222292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity is a risk factor for developing critical condition in COVID-19 patients: A systematic review and meta-analysis.
    Földi M; Farkas N; Kiss S; Zádori N; Váncsa S; Szakó L; Dembrovszky F; Solymár M; Bartalis E; Szakács Z; Hartmann P; Pár G; Erőss B; Molnár Z; Hegyi P; Szentesi A;
    Obes Rev; 2020 Oct; 21(10):e13095. PubMed ID: 32686331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity is associated with severe disease and mortality in patients with coronavirus disease 2019 (COVID-19): a meta-analysis.
    Cai Z; Yang Y; Zhang J
    BMC Public Health; 2021 Aug; 21(1):1505. PubMed ID: 34348687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity in COVID-19: A Systematic Review and Meta-analysis.
    Ho JSY; Fernando DI; Chan MY; Sia CH
    Ann Acad Med Singap; 2020 Dec; 49(12):996-1008. PubMed ID: 33463658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic corticosteroids for the treatment of COVID-19.
    Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe.
    Vardavas CI; Mathioudakis AG; Nikitara K; Stamatelopoulos K; Georgiopoulos G; Phalkey R; Leonardi-Bee J; Fernandez E; Carnicer-Pont D; Vestbo J; Semenza JC; Deogan C; Suk JE; Kramarz P; Lamb F; Penttinen P
    Eur Respir Rev; 2022 Dec; 31(166):. PubMed ID: 36323422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity or increased body mass index and the risk of severe outcomes in patients with COVID-19: A protocol for systematic review and meta-analysis.
    Yang Y; Wang L; Liu J; Fu S; Zhou L; Wang Y
    Medicine (Baltimore); 2022 Jan; 101(1):e28499. PubMed ID: 35029905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
    Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity aggravates COVID-19: An updated systematic review and meta-analysis.
    Yang J; Tian C; Chen Y; Zhu C; Chi H; Li J
    J Med Virol; 2021 May; 93(5):2662-2674. PubMed ID: 33200825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis.
    Vai B; Mazza MG; Delli Colli C; Foiselle M; Allen B; Benedetti F; Borsini A; Casanova Dias M; Tamouza R; Leboyer M; Benros ME; Branchi I; Fusar-Poli P; De Picker LJ
    Lancet Psychiatry; 2021 Sep; 8(9):797-812. PubMed ID: 34274033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic anticoagulants for people hospitalised with COVID-19.
    Flumignan RL; Tinôco JDS; Pascoal PI; Areias LL; Cossi MS; Fernandes MI; Costa IK; Souza L; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013739. PubMed ID: 33502773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression.
    Singh R; Rathore SS; Khan H; Karale S; Chawla Y; Iqbal K; Bhurwal A; Tekin A; Jain N; Mehra I; Anand S; Reddy S; Sharma N; Sidhu GS; Panagopoulos A; Pattan V; Kashyap R; Bansal V
    Front Endocrinol (Lausanne); 2022; 13():780872. PubMed ID: 35721716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-existing cerebrovascular disease and poor outcomes of COVID-19 hospitalized patients: a meta-analysis.
    Patel U; Malik P; Shah D; Patel A; Dhamoon M; Jani V
    J Neurol; 2021 Jan; 268(1):240-247. PubMed ID: 32770412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.